Skip to main content
Equibles

Abbot Financial Management, Inc.

Position in PBE — Invesco Biotechnology & Genome ETF

CIK 1714341 ANDOVER, MA
Back to PBE Full portfolio

All Filings in PBE

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 PBE $983,811 12,425
2025-12-31 PBE $1,020,713 12,425
2025-09-30 PBE $868,134 12,425
2025-06-30 PBE $815,672 12,725
2025-03-31 PBE $837,408 13,200
2024-12-31 PBE $888,175 13,350
2024-09-30 PBE $932,097 13,350
2024-06-30 PBE $939,745 14,500
2024-03-31 PBE $938,440 14,500
2023-12-31 PBE $987,600 15,000
2023-09-30 PBE $872,712 15,300
2023-06-30 PBE $949,995 15,500
2023-03-31 PBE $987,058 15,725
2022-12-31 PBE $998,537 15,725
2022-09-30 PBE $968,089 16,425
2022-06-30 PBE $970,032 16,800
2022-03-31 PBE $1,073,119 17,300
2021-12-31 PBE $1,263,977 17,750
2021-09-30 PBE $1,429,444 19,100
2021-06-30 PBE $1,477,003 19,100
2021-03-31 PBE $1,413,653 19,150
2020-12-31 PBE $1,346,496 19,200
2020-09-30 PBE $1,087,104 19,200
2020-06-30 PBE $1,142,092 19,600
2020-03-31 PBE $911,204 19,600